188,000 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Purchased by Clark Estates Inc. NY
Clark Estates Inc. NY bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 188,000 shares of the biopharmaceutical company’s stock, valued at approximately $2,198,000. Clark Estates Inc. NY owned 0.18% of Catalyst Pharmaceuticals […]